Luminex


Luminex Corporation was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biological testing technologies with applications throughout the life-sciences industry. The company’s open-architecture xMAP®  technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately.

Systems using xMAP technology (formerly known as LabMAP®) perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer. Using lasers and high-speed digital-signal processors, the analyzer simultaneously identifies the bioassay and measures the results, all in real time.

Write a Review

Join 200,000 Scientists Online

Become a member for FREE for access to:

  • 250,000 full product and supplier listings
  • 10,000 user reviews and comments
  • Daily news and videos
  • 2,500 application notes and videos
  • 2,000 of the best jobs in Science

Don't miss out!

Join The Community Today